---
title: "Wedbush Keeps Their Hold Rating on Zentalis Pharmaceuticals (ZNTL)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286285617.md"
description: "Wedbush analyst maintained a Hold rating on Zentalis Pharmaceuticals today and set a price target of $4.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In addition to Wedbush, Zentalis Pharmaceuticals also received a Hold from Morgan Stanley’s Michael Ulz in a report issued today. However, on the same day, Oppenheimer reiterated a Buy rating on Zentalis Pharmaceuticals (NASDAQ: ZNTL)."
datetime: "2026-05-13T15:16:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286285617.md)
  - [en](https://longbridge.com/en/news/286285617.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286285617.md)
---

# Wedbush Keeps Their Hold Rating on Zentalis Pharmaceuticals (ZNTL)

Wedbush analyst maintained a Hold rating on Zentalis Pharmaceuticals today and set a price target of $4.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Wedbush, Zentalis Pharmaceuticals also received a Hold from Morgan Stanley’s Michael Ulz in a report issued today. However, on the same day, Oppenheimer reiterated a Buy rating on Zentalis Pharmaceuticals (NASDAQ: ZNTL).

### Related Stocks

- [ZNTL.US](https://longbridge.com/en/quote/ZNTL.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Skye Bioscience opens higher-dose Cohort 2 in nimacimab obesity Phase 2a study](https://longbridge.com/en/news/287053007.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)